Novartis agrees to make ingredients Roche's Actemra for COVID-19 patients – Reuters

Novartis agrees to make ingredients Roche’s Actemra for COVID-19 patients – Reuters

Swiss drugmaker Novartis has signed a deal to make ingredients for Roche’s Actemra treatment that is being repurposed for people with COVID-19, the company said on Thursday.

Read More…

You May Also Like